Bing Yu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Bing Yu has a total of 455 co-authors. Here are the top co-authors by number of shared publications:
- Hailin Cong
Qingdao University
127 shared publications Youqing Shen
College of Chemistry and Chemical Engineering College of Materials Science and Engineering Institute of Biomedical Materials and Engineering Qingdao University Qingdao 266071 China
81 shared publicationsHailin Cong
School of Mechanical Engineering Shandong University of Technology Zibo China
64 shared publicationsHai-Lin Cong
College of Chemistry and Chemical Engineering, College of Materials Science and Engineering, Institute of Biomedical Materials and Engineering, State Key Laboratory of Bio-Fibers and Eco-Textiles, Qingdao University, Qingdao, China
61 shared publicationsYou-Qing Shen
College of Chemistry and Chemical Engineering, College of Materials Science and Engineering, Institute of Biomedical Materials and Engineering, State Key Laboratory of Bio-Fibers and Eco-Textiles, Qingdao University, Qingdao, China
40 shared publicationsSong Wang
25 shared publications
Latest Publications
- 19 November 2026
- Published by Wiley in The Chemical Record
Recent Advances in Visible‐Light‐Activated Phosphorescent Carbon Dots: Design Strategies, Photophysical Mechanisms, and Emerging Applications
Phosphorescent carbon dots have emerged as a promising class of luminescent nanomaterials, attracting extensive research interest due to their unique room‐temperature phosphorescence (RTP), low cost, and excellent biocompatibility. However, achieving ultralong RTP under visible light, particularly low‐energy white light or natural sunlight, remains challenging for practical applications. This review critically examines recent advances in visible‐light‐activated ultralong RTP carbon dots (RTP‐CDs) and, where supported by the reported experimental conditions, distinguishes systems evaluated using dedicated visible‐light sources from those activated by ambient white light, mobile‐phone illumination, or sunlight. We analyze key material‐design strategies—including matrix confinement, self‐protective carbonization, heteroatom doping, and polymer composite engineering—that stabilize triplet excitons and enhance intersystem crossing (ISC). The underlying photophysical mechanisms, including ISC, spin–orbit coupling, thermally activated delayed fluorescence, and organic long‐persistent luminescence, are critically discussed. Furthermore, emerging applications in high‐level information encryption, advanced bioimaging and therapeutics, white light‐emitting diodes, and sensing platforms are evaluated with consideration of their practical excitation requirements. Finally, we discuss current challenges and future research directions, providing a guiding framework for the rational design of next‐generation RTP‐CD‐based smart materials.
- 19 November 2026
- Published by Wiley in The Chemical Record
Recent Advances in Visible‐Light‐Activated Phosphorescent Carbon Dots: Design Strategies, Photophysical Mechanisms, and Emerging Applications
Phosphorescent carbon dots have emerged as a promising class of luminescent nanomaterials, attracting extensive research interest due to their unique room‐temperature phosphorescence (RTP), low cost, and excellent biocompatibility. However, achieving ultralong RTP under visible light, particularly low‐energy white light or natural sunlight, remains challenging for practical applications. This review critically examines recent advances in visible‐light‐activated ultralong RTP carbon dots (RTP‐CDs) and, where supported by the reported experimental conditions, distinguishes systems evaluated using dedicated visible‐light sources from those activated by ambient white light, mobile‐phone illumination, or sunlight. We analyze key material‐design strategies—including matrix confinement, self‐protective carbonization, heteroatom doping, and polymer composite engineering—that stabilize triplet excitons and enhance intersystem crossing (ISC). The underlying photophysical mechanisms, including ISC, spin–orbit coupling, thermally activated delayed fluorescence, and organic long‐persistent luminescence, are critically discussed. Furthermore, emerging applications in high‐level information encryption, advanced bioimaging and therapeutics, white light‐emitting diodes, and sensing platforms are evaluated with consideration of their practical excitation requirements. Finally, we discuss current challenges and future research directions, providing a guiding framework for the rational design of next‐generation RTP‐CD‐based smart materials.
- 5 November 2026
- Published by American Chemical Society (ACS) in ACS Nano
- Vol. 20 (45) , 30681-30697
Membrane-Context Screening Identifies a Functionally Active Peptide for Targeted Nanodelivery in Triple-Negative Breast Cancer
Ligand binding identified during screening does not necessarily translate into improved nanocarrier delivery. Here, we report a membrane-context screening strategy that uses BT-549 cell membrane-functionalized silica microspheres to identify peptide ligands with preserved nanodelivery activity. From a 7-mer combinatorial library, P1 (KFYVSGT) was selected as a membrane-enriched peptide candidate based on its preferential retention by the membrane-functionalized stationary phase relative to bare silica. After conjugation to PEG–PCL micelles, P1 preserved the nanocarrier’s size, charge, morphology, stability, and drug-loading capacity, yet markedly enhanced biological performance. P1-functionalized micelles increased BT-549 cellular uptake by approximately 5-fold and tumor accumulation by about 3-fold in a BT-549 xenograft model. When loaded with doxorubicin, P1 micelles restrained tumor expansion to 1.96-fold of the initial volume, compared with 4.83-fold for nontargeted micelles, with favorable preliminary systemic tolerance. Competitive uptake, energy depletion, peptide-affinity capture, inhibition, colocalization, and docking analyses suggest that P1 activity is associated with a Galectin-1-related membrane environment. This work establishes membrane-context screening as a practical route to function-preserving peptide ligands for targeted nanodelivery.
- 5 November 2026
- Published by American Chemical Society (ACS) in ACS Nano
- Vol. 20 (45) , 30681-30697
Membrane-Context Screening Identifies a Functionally Active Peptide for Targeted Nanodelivery in Triple-Negative Breast Cancer
Ligand binding identified during screening does not necessarily translate into improved nanocarrier delivery. Here, we report a membrane-context screening strategy that uses BT-549 cell membrane-functionalized silica microspheres to identify peptide ligands with preserved nanodelivery activity. From a 7-mer combinatorial library, P1 (KFYVSGT) was selected as a membrane-enriched peptide candidate based on its preferential retention by the membrane-functionalized stationary phase relative to bare silica. After conjugation to PEG–PCL micelles, P1 preserved the nanocarrier’s size, charge, morphology, stability, and drug-loading capacity, yet markedly enhanced biological performance. P1-functionalized micelles increased BT-549 cellular uptake by approximately 5-fold and tumor accumulation by about 3-fold in a BT-549 xenograft model. When loaded with doxorubicin, P1 micelles restrained tumor expansion to 1.96-fold of the initial volume, compared with 4.83-fold for nontargeted micelles, with favorable preliminary systemic tolerance. Competitive uptake, energy depletion, peptide-affinity capture, inhibition, colocalization, and docking analyses suggest that P1 activity is associated with a Galectin-1-related membrane environment. This work establishes membrane-context screening as a practical route to function-preserving peptide ligands for targeted nanodelivery.
A Broad‐Spectrum Tumor‐Penetrating Peptide WKASC: Design, Screening, and Platform Development for Cancer Therapy
Conventional cancer therapies are often limited by inadequate drug accumulation in tumors, drug resistance, and systemic toxicity. Cell‐penetrating peptides (CPPs) offer a promising strategy to enhance intracellular drug delivery. In this study, we designed a novel tumor‐penetrating peptide, P3 (sequence: Trp‐Lys‐Ala‐Ser‐Cys), which demonstrated exceptional transmembrane efficiency with a broad‐spectrum penetration profile across various tumor cell lines (including HeLa, HGC‐27, and A549 etc.). Notably, it achieved an internalization rate of 47.4% in A549 cells within 15 min. This peptide was further engineered into an amphiphilic polymer, P3‐Mal‐PEG‐PCL, which self‐assembled into pH‐responsive micelles. Doxorubicin (DOX) was encapsulated within these micelles to form DOX@P3P, which was subsequently coated with hyaluronic acid (HA) to create the final actively targeted nanoparticles, DOX@P3P@HA (PHA NPs), leveraging the cluster of differentiation 44 (CD44) receptor overexpression on cancer cells. The PHA NPs displayed excellent biosafety, colloidal stability, and improved drug distribution. In a murine tumor model, treatment with PHA NPs resulted in a remarkable 76.6% reduction in tumor volume, underscoring its potent antitumor efficacy and highlighting its potential as a robust platform for targeted cancer chemotherapy.
A Broad‐Spectrum Tumor‐Penetrating Peptide WKASC: Design, Screening, and Platform Development for Cancer Therapy
Conventional cancer therapies are often limited by inadequate drug accumulation in tumors, drug resistance, and systemic toxicity. Cell‐penetrating peptides (CPPs) offer a promising strategy to enhance intracellular drug delivery. In this study, we designed a novel tumor‐penetrating peptide, P3 (sequence: Trp‐Lys‐Ala‐Ser‐Cys), which demonstrated exceptional transmembrane efficiency with a broad‐spectrum penetration profile across various tumor cell lines (including HeLa, HGC‐27, and A549 etc.). Notably, it achieved an internalization rate of 47.4% in A549 cells within 15 min. This peptide was further engineered into an amphiphilic polymer, P3‐Mal‐PEG‐PCL, which self‐assembled into pH‐responsive micelles. Doxorubicin (DOX) was encapsulated within these micelles to form DOX@P3P, which was subsequently coated with hyaluronic acid (HA) to create the final actively targeted nanoparticles, DOX@P3P@HA (PHA NPs), leveraging the cluster of differentiation 44 (CD44) receptor overexpression on cancer cells. The PHA NPs displayed excellent biosafety, colloidal stability, and improved drug distribution. In a murine tumor model, treatment with PHA NPs resulted in a remarkable 76.6% reduction in tumor volume, underscoring its potent antitumor efficacy and highlighting its potential as a robust platform for targeted cancer chemotherapy.
- 1 September 2026
- Published by Elsevier in Materials Science and Engineering: C
- Vol. 190, 215154
Hydrogen bond-organized β-sheet self-assembling peptide hydrogel integrating rapid hemostasis and wound repair
- 1 September 2026
- Published by Elsevier in Materials Science and Engineering: C
- Vol. 190, 215154
Hydrogen bond-organized β-sheet self-assembling peptide hydrogel integrating rapid hemostasis and wound repair
- 4 August 2026
- Published by American Chemical Society (ACS) in ACS Applied Polymer Materials
MMP-Responsive TAT-Containing Polymeric Micelles for Cascade Delivery of Oxaliplatin in Gastric Cancer Therapy
Although nanodrug delivery systems have advanced cancer therapy, limited tumor penetration and inefficient intracellular transport still restrict their therapeutic efficacy. Herein, we constructed a matrix metalloproteinase (MMP)-responsive, TAT-containing polymeric micelle, O@MTPP, for cascade delivery of oxaliplatin in gastric cancer. O@MTPP integrates an MMP-2/9-cleavable peptide, MTP (GPLGIAG), with the cell-penetrating and nuclear-localization-associated TAT peptide (CYGRKKRRQRRR). In the tumor microenvironment, MMP-2/9-mediated cleavage triggers charge conversion, enhancing tumor-cell internalization and penetration-associated distribution. After cellular uptake, TAT further promotes nuclear-associated accumulation of the nanocarrier-associated payload, supporting improved intracellular delivery of oxaliplatin. This cascade delivery strategy enhanced tumor accumulation, strengthened antitumor activity, and induced immunogenic cell death (ICD)-associated immune responses, including calreticulin exposure, high mobility group box 1 (HMGB-1) expression, increased tumor necrosis factor-α (TNF-α), interferon-γ (IFN-γ), and interleukin-12 (IL-12) levels, and decreased interleukin-6 (IL-6). Overall, O@MTPP provides an enzyme-activated cascade delivery strategy for overcoming tissue-level and intracellular barriers in oxaliplatin-based gastric cancer therapy.
- 4 August 2026
- Published by American Chemical Society (ACS) in ACS Applied Polymer Materials
MMP-Responsive TAT-Containing Polymeric Micelles for Cascade Delivery of Oxaliplatin in Gastric Cancer Therapy
Although nanodrug delivery systems have advanced cancer therapy, limited tumor penetration and inefficient intracellular transport still restrict their therapeutic efficacy. Herein, we constructed a matrix metalloproteinase (MMP)-responsive, TAT-containing polymeric micelle, O@MTPP, for cascade delivery of oxaliplatin in gastric cancer. O@MTPP integrates an MMP-2/9-cleavable peptide, MTP (GPLGIAG), with the cell-penetrating and nuclear-localization-associated TAT peptide (CYGRKKRRQRRR). In the tumor microenvironment, MMP-2/9-mediated cleavage triggers charge conversion, enhancing tumor-cell internalization and penetration-associated distribution. After cellular uptake, TAT further promotes nuclear-associated accumulation of the nanocarrier-associated payload, supporting improved intracellular delivery of oxaliplatin. This cascade delivery strategy enhanced tumor accumulation, strengthened antitumor activity, and induced immunogenic cell death (ICD)-associated immune responses, including calreticulin exposure, high mobility group box 1 (HMGB-1) expression, increased tumor necrosis factor-α (TNF-α), interferon-γ (IFN-γ), and interleukin-12 (IL-12) levels, and decreased interleukin-6 (IL-6). Overall, O@MTPP provides an enzyme-activated cascade delivery strategy for overcoming tissue-level and intracellular barriers in oxaliplatin-based gastric cancer therapy.
- 28 July 2026
- Published by Elsevier in Food Research International
- Vol. 242 (Pt 5) , 120171
Advancements in the research of antioxidant peptides: A comprehensive overview
- 28 July 2026
- Published by Elsevier in Food Research International
- Vol. 242 (Pt 5) , 120171
Advancements in the research of antioxidant peptides: A comprehensive overview
- Open Access
- 26 July 2026
- Published by Springer Nature in Cancer Nanotechnology
- Vol. 17 (1)
Chemo-phototherapeutic co-delivery nanosystems for colorectal cancer: a review
- 26 July 2026
- Published by Springer Nature in Cancer Nanotechnology
- Vol. 17 (1)
Open AccessChemo-phototherapeutic co-delivery nanosystems for colorectal cancer: a review
- 1 July 2026
- Published by American Chemical Society (ACS) in Biomacromolecules
- Vol. 27 (8) , 5195-5211
Screening of Cationic Short Peptide RKIIIRW and Its Antimelanoma Nano Delivery System
Melanoma is one of the most lethal cancers in the clinic; cationic peptides have shown great potential in the treatment of melanoma. The large pore volume and high specific surface area of mesoporous silica nanoparticles (MSNs) allow for efficient loading of drugs, while surface-functionalized MSNs can further improve drug stability and carrier targeting. Polydopamine (PDA) coating is an effective surface modification method that provides an additional protective layer to prevent premature drug release during delivery and can prolong the treatment time. Hyaluronic acid (HA) is a commonly used tumor-targeting molecule that binds to HA receptors on the surface of tumor cells, thereby facilitating drug internalization and enhancing the therapeutic effect of the drug. In this paper, the cationic short peptide RKIIIRW, which can effectively inhibit B16F10 cells, was successfully screened by solid-phase synthesis combined with MTT assay and cell membrane chromatography. By combining the cationic short peptide RKIIIRW with MSNs and further surface modification with PDA coating and HA targeting molecules, a nanodrug delivery system with targeted and controllable release characteristics was prepared. This drug-delivery system enhances the efficacy of cationic short peptides while minimizing side effects, offering a more effective therapeutic strategy for melanoma.
- 1 July 2026
- Published by American Chemical Society (ACS) in Biomacromolecules
- Vol. 27 (8) , 5195-5211
Screening of Cationic Short Peptide RKIIIRW and Its Antimelanoma Nano Delivery System
Melanoma is one of the most lethal cancers in the clinic; cationic peptides have shown great potential in the treatment of melanoma. The large pore volume and high specific surface area of mesoporous silica nanoparticles (MSNs) allow for efficient loading of drugs, while surface-functionalized MSNs can further improve drug stability and carrier targeting. Polydopamine (PDA) coating is an effective surface modification method that provides an additional protective layer to prevent premature drug release during delivery and can prolong the treatment time. Hyaluronic acid (HA) is a commonly used tumor-targeting molecule that binds to HA receptors on the surface of tumor cells, thereby facilitating drug internalization and enhancing the therapeutic effect of the drug. In this paper, the cationic short peptide RKIIIRW, which can effectively inhibit B16F10 cells, was successfully screened by solid-phase synthesis combined with MTT assay and cell membrane chromatography. By combining the cationic short peptide RKIIIRW with MSNs and further surface modification with PDA coating and HA targeting molecules, a nanodrug delivery system with targeted and controllable release characteristics was prepared. This drug-delivery system enhances the efficacy of cationic short peptides while minimizing side effects, offering a more effective therapeutic strategy for melanoma.
- 12 June 2026
- Published by Wiley in Journal of Applied Polymer Science
- Vol. 143 (34)
Durable Antibacterial Polypropylene Nonwoven Fabrics via Facile Quaternary Ammonium Modification
Infectious diseases caused by bacterial transmission pose a significant threat to public health and safety. Personal protective equipment (PPE) is essential for limiting disease transmission and protecting public health. Conventional polypropylene (PP) nonwoven filtration layers used in protective masks lack intrinsic antibacterial activity, which may lead to microbial accumulation during prolonged use, thereby posing potential health and safety risks, whereas frequent replacement of disposable masks contributes to plastic pollution. Therefore, reusable antibacterial mask materials have attracted increasing attention. In this study, an organosilane quaternary ammonium salt, DC‐5700, was spray‐coated onto PP nonwoven fabrics to fabricate quaternary ammonium‐functionalized polypropylene (QPP) nonwovens. The obtained QPP nonwovens exhibited effective antibacterial activity against Escherichia coli and Staphylococcus aureus , while maintaining good thermal stability and mechanical properties. No obvious coating detachment was observed after repeated washing, and a certain degree of antibacterial activity was retained after 20 washing cycles, indicating acceptable washing durability. Moreover, the modified nonwovens showed favorable biocompatibility. While maintaining good air permeability and filtration efficiency, the QPP nonwovens exhibited antibacterial functionality with acceptable washing durability, highlighting their potential as reusable antibacterial filtration layers for protective masks.
- 12 June 2026
- Published by Wiley in Journal of Applied Polymer Science
- Vol. 143 (34)
Durable Antibacterial Polypropylene Nonwoven Fabrics via Facile Quaternary Ammonium Modification
Infectious diseases caused by bacterial transmission pose a significant threat to public health and safety. Personal protective equipment (PPE) is essential for limiting disease transmission and protecting public health. Conventional polypropylene (PP) nonwoven filtration layers used in protective masks lack intrinsic antibacterial activity, which may lead to microbial accumulation during prolonged use, thereby posing potential health and safety risks, whereas frequent replacement of disposable masks contributes to plastic pollution. Therefore, reusable antibacterial mask materials have attracted increasing attention. In this study, an organosilane quaternary ammonium salt, DC‐5700, was spray‐coated onto PP nonwoven fabrics to fabricate quaternary ammonium‐functionalized polypropylene (QPP) nonwovens. The obtained QPP nonwovens exhibited effective antibacterial activity against Escherichia coli and Staphylococcus aureus , while maintaining good thermal stability and mechanical properties. No obvious coating detachment was observed after repeated washing, and a certain degree of antibacterial activity was retained after 20 washing cycles, indicating acceptable washing durability. Moreover, the modified nonwovens showed favorable biocompatibility. While maintaining good air permeability and filtration efficiency, the QPP nonwovens exhibited antibacterial functionality with acceptable washing durability, highlighting their potential as reusable antibacterial filtration layers for protective masks.
- 6 June 2026
- Published by Elsevier in Phytomedicine
- Vol. 158, 158398
Screening and enrichment of quercetin from Tetrastigma hemsleyanum Diels & Gilg toward targeted micellar delivery for lung cancer therapy
- 6 June 2026
- Published by Elsevier in Phytomedicine
- Vol. 158, 158398
Screening and enrichment of quercetin from Tetrastigma hemsleyanum Diels & Gilg toward targeted micellar delivery for lung cancer therapy